USPTO serial 86524052
RAXONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 17, 2015
- Examiner
- SAKAI, ADA HAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with RAXONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG
Pratteln, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
PATRICK J. CONCANNON Locke Lord LLPPO BOX 1470Church Street StationNEW YORK, NY 10008-1470Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals used in industry and science | SECTION 8 - CANCELLED | — |
| 005 | pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss | SECTION 8 - CANCELLED | — |
| 042 | computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
- Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
- Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named RAXONE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 27, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 17, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 20, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 20, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 26, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 21, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 13, 2015 | DMCC | DATA MODIFICATION COMPLETED | — |
| May 13, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 12, 2015 | DMCC | DATA MODIFICATION COMPLETED | — |
| May 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| May 11, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 13, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 11, 2015 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Feb 11, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 11, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 9, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 7, 2015 | NWAP | NEW APPLICATION ENTERED | — |